The Patent Finder

Terms ending in 2041

Intervet Inc.

Every in-force patent on Intervet Inc.'s record whose computed term ends in 2041, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 12,797,461Swine Influenza a Virus Vaccine Comprising a Nucleic Acid Construct Comprising First, Second and Third Nucleic Acid Sequences Encoding Distinct Neuraminidase Antigens of the Virus
In force
 · Medium confidence
Intervet Inc.In forceMedium confidence
US 12,285,593Device for Administering a Fluid
In force
 · Medium confidence
Intervet Inc.In forceMedium confidence
US 12,018,020Crystalline Forms of 1-[(3R,4S)-4-Cyanotetrahydropyran-3-YL]-3-[(2-Fluoro-6-Methoxy-4-Pyridyl)Amino]Pyrazole-4-Carboxamide
In force
 · High confidence
Intervet Inc.In forceHigh confidence
US 12,023,374A Vaccine for Protection Against Streptococcus Suis
In force
 · High confidence
Intervet Inc.In forceHigh confidence
US 12,161,713Prime-Boost Vaccination Regimen
In force
 · High confidence
Intervet Inc.In forceHigh confidence
US 12,297,459Novel Porcine Rotavirus
In force
 · High confidence
Intervet Inc.In forceHigh confidence
US 12,214,027Stabilisation of Live Mollicutes Bacteria in a Liquid Composition
In force
 · High confidence
Intervet Inc.In forceHigh confidence
7 of 7 patents shown. Soonest term end first, then patent number.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited